Sign in
CompletedPhase 4

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Key facts

Who runs it
Seoul National University Bundang Hospital
Where
South Korea8 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
528 people enrolled
Started
23 Jun 2022
Ended
2 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Aspirin 100mg
  • Clopidogrel 75mg
Record updated
19 December 2025

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • subjects over 19 years old
  • subjects with modified Rankin Scale (mRS) ≤ 2
  • subjects with unruptured intracranial aneurysms
  • subjects with appropriated aspirin and clopidogrel reaction units after dual antiplatelet preparation (100 mg of aspirin and 75 mg of clopidogrel) for at least 5 days before procedure [measured using VerifyNow]; aspirin reaction unit (ARU) < 550; P2Y12 reaction unit (PRU): 85~219
  • subjects who agreed to this study (with informed consent)

Who cannot take part

  • subjects with an allergic reaction to antiplatelets (aspirin and clopidogrel) or contrast
  • subjects with a high risk of hemorrhage such ICH or severe gastric ulceration
  • subjects with liver diseases (> 100IU/L of aspartate aminotransferase or alanine aminotransferase)
  • subjects with underlying diseases that need to maintain dual antiplatelet drugs or anticoagulants
  • subjects with a high risk of strokes (atrial fibrillation, over 70% cerebral artery stenosis or cerebral artery occlusion, moyamoya disease, vascular malformations, etc)
  • subjects with uncontrolled congestive heart failure or angina
  • subjects with malignant tumors
  • subjects with life-threatening diseases
  • subjects with medical conditions with a life expectancy of less than two years
  • subjects with renal diseases (> 2mg/dL of serum creatinine)
  • subjects with a positive pregnancy test (serum or urine)
  • subjects with neurological deficits (mRS ≥ 3)
  • subjects with coagulopathy
  • subjects with thrombocytopenia (<100,000/mm3)
  • subjects who are unconscious at the time of diagnosis
  • subjects who are unable to complete the required follow-ups
  • subjects who are determined to be disqualified by researchers

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Comparison of duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms

The 2 groups in the trial

  • short-term dual antiplatelet groupExisting treatment, for comparison

    Patients with unruptured intracranial aneurysms received dual antiplatelet agents (100mg of aspirin and 75mg of clopidogrel) for at least five days before coil embolization. One day prior to coiling, aspirin reaction units (ARU) and P2Y12 reaction units (PRU) were measured using VerifyNow. Patients with proper aspirin and clopidogrel reaction units (ARU \< 550 and PRU 85 \~219) will be enrolled in this study. After stent-assisted coiling, dual antiplatelet treatment continued for 6 months; after that time, this therapy will be exchanged for daily oral 100mg of aspirin for 18 months after coiling

    Treatment: Aspirin 100mg and Clopidogrel 75mg

  • long-term dual antiplatelet groupTreatment being tested

    Patients with unruptured intracranial aneurysms received dual antiplatelet agents (100mg of aspirin and 75mg of clopidogrel) for at least five days before coil embolization. One day prior to coiling, aspirin reaction units (ARU) and P2Y12 reaction units (PRU) were measured using VerifyNow. Patients with proper aspirin and clopidogrel reaction units (ARU \< 550 and PRU 85 \~219) will be enrolled in this study. After stent-assisted coiling, dual antiplatelet treatment continued for 12 months; after that time, this therapy will be exchanged for daily oral 100mg of aspirin for 18 months after coiling.

    Treatment: Aspirin 100mg and Clopidogrel 75mg

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling of Unruptured Intracranial Aneurysms: A Prospective Randomized Multicenter Trial
Record updated
19 December 2025